Alcohol dehydrogenase: An autoantibody target in patients with alcoholic liver disease

Y. Ma, M. Meregalli, S. Hodges, N. Davies, D. P. Bogdanos, S. Fargion, G. Fiorelli, Diego Vergani

Research output: Contribution to journalArticlepeer-review


The link between alcohol consumption and liver disease is not direct and several factors including autoimmunity to hepatocyte components have been implicated. We have previously identified alcohol dehydrogenase (ADH) as an autoantigen in autoimmune liver disease and in a proportion of patients with alcoholic liver disease. The aim of the present study is to investigate the association between the presence of anti-ADH antibodies, alcohol consumption and severity of liver damage in alcoholic patients. The presence of antibodies to human ADH β2 and horse ADH was investigated in 108 patients with documented history of alcohol consumption and alcohol related liver disease, 86 being active alcohol abusers and 22 on sustained alcohol withdrawal, 39 with non-alcohol related disease and 22 normal subjects. Antibodies to either ADH form were more frequently detected in active alcohol abusers (55/86, 64%) than in patients on sustained alcohol withdrawal longer than 6 months (1/8, 13%, P

Original languageEnglish
Pages (from-to)173-182
Number of pages10
JournalInternational Journal of Immunopathology and Pharmacology
Issue number1
Publication statusPublished - Jan 2005


  • Alcohol consumption
  • Autoantibodies
  • Autoimmunity
  • Hepatitis C virus
  • Isoenzymes

ASJC Scopus subject areas

  • Pharmacology


Dive into the research topics of 'Alcohol dehydrogenase: An autoantibody target in patients with alcoholic liver disease'. Together they form a unique fingerprint.

Cite this